YF-VAX 1 dose vials
Ended Awarded Last action
- Contract number
- SPE2DR26FSCD5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $125,908
Award facts
- Contract value 100% obligated
- $125,908.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a firm fixed-price delivery order valued at $125,908 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vial configurations. The delivery order, issued on January 14, 2026, carries an ultimate completion date of February 5, 2026, with performance taking place at the contractor's Park Ridge facility. This award was made without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to ensure reliable pharmaceutical supply to Department of Defense military healthcare facilities worldwide. The prime indefinite delivery contract, valued at $499,999,999 and awarded in November 2025, authorizes the Defense Logistics Agency to issue delivery orders for a comprehensive range of pharmaceutical products and medical consumables. DMS Pharmaceutical Group's established performance across numerous prior delivery orders demonstrates its capability as a critical pharmaceutical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FSCD5?
SPE2DR26FSCD5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FSCD5 worth?
The government has obligated $125,908 on SPE2DR26FSCD5.
Is contract SPE2DR26FSCD5 an order under another contract?
Yes. SPE2DR26FSCD5 is a delivery order under SPE2DR25D9316, an indefinite delivery contract.
Was contract SPE2DR26FSCD5 competed?
The extent of competition for SPE2DR26FSCD5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award